Table 2.
Parameters OXPHOS | Age | ||
---|---|---|---|
3 months | 17 months | 36 months | |
Complex I | |||
RCI (S3.S4–1) | 3.63 ± 0.19 | 3.25 ± 0.12 | 2.86 ± 0.08*+ |
ADP:O (nmol ADP.nAtO-1) | 2.67 ± 0.02 | 2.76 ± 0.02* | 2.63 ± 0.04+ |
QO2S3 (nAtO.mg prot-1.min-1) | 76.73 ± 2.80 | 58.74 ± 2.89** | 48.68 ± 1.76***+ |
QO2S4 (nAtO.mg prot-1.min-1) | 21.98 ± 1.52 | 18.16 ± 0.75 | 17.14 ± 0.80 |
OPR (nmol ATP.mg prot-1.min-1) | 205.23 ± 6.08 | 163.97 ± 9.35** | 127.27 ± 5.26***++ |
Complex II | |||
RCI (S3.S4–1) | 1.66 ± 0.33 | 1.65 ± 0.06 | 1.64 ± 0.04 |
ADP:O (nmol ADP.nAtO-1) | 1.69 ± 0.03 | 1.63 ± 0.04 | 1.72 ± 0.03 |
QO2S3 (nAtO.mg prot-1.min-1) | 87.87 ± 4.36 | 68.20 ± 3.97** | 51.04 ± 2.72***++ |
QO2S4 (nAtO.mg prot-1.min-1) | 53.02 ± 2.93 | 41.66 ± 2.75* | 31.33 ± 1.99***+ |
OPR (nmol ATP.mg prot-1.min-1) | 205.23 ± 6.08 | 163.97 ± 9.35** | 127.27 ± 5.26***++ |